Society for Cardiovascular Angiography and Interventions

ORLANDO, Fla. — Transcatheter aortic valve replacement with moderate sedation produces similar results to transcatheter aortic valve replacement with general anesthesia, according to the results of a retrospective study presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

ORLANDO, Fla. — In this video exclusive, Timothy D. Henry, MD, provides investigator insight on the RENEW study, which evaluated use of granulocyte colony-stimulating factor mobilized CD34+ cell therapy as treatment for refractory angina.

ORLANDO, Fla. — Women undergoing transcatheter aortic valve replacement had more vascular complications than men, but they had a better mortality rate at 1 year, according to findings reported at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

ORLANDO, Fla. — In a study of men and women younger than 55 years requiring PCI for ACS, women were at greater ischemic risk but less likely to receive prasugrel than men, according to data presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

ORLANDO, Fla. — Mainly due to increased rates of stent thrombosis, a self-expanding bare-metal stent failed to prove noninferiority to a balloon-expandable BMS, according to the results of the APPOSITION V trial.

ORLANDO, Fla. — Three-year data from the ORBIT II trial demonstrate durable outcomes after use of an orbital atherectomy device in severely calcified arteries prior to stent placement, Jeffrey W. Chambers, MD, said during a video interview.

ORLANDO, Fla. — In the BRAVO 3 study population of patients undergoing transfemoral transcatheter aortic valve replacement, outcomes did not differ between men and women, according to data presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.

ORLANDO, Fla. — In this video, Jay S. Giri, MD, MPH, discusses a “minimalist” approach to transfemoral transcatheter aortic valve replacement.

ORLANDO, Fla. — A next-generation orbital atherectomy system was effective at treating severely calcified coronary lesions, according to results from the COAST study.

ORLANDO, Fla. — A cell therapy to treat patients with refractory angina showed positive outcomes in a trial that was truncated by its sponsor, researchers reported at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.